Large B-Cell Lymphoma With 11q Aberration
1 clinical trials · Condition
◉ Watch Large B-Cell Lymphoma With 11q Aberration
| Record | Firm | Date |
|---|---|---|
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
Track Large B-Cell Lymphoma With 11q Aberration automatically
Every clearance here is in the API, with alerts when new ones post.